ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
John C. Kucharczuk
W. Roy Smythe
Larry R. Kaiser
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kucharczuk, J. C.
Right arrow Articles by Kaiser, L. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kucharczuk, J. C.
Right arrow Articles by Kaiser, L. R.
Related Collections
Right arrowRelated Articles

Ann Thorac Surg 1995;60:593-597
© 1995 The Society of Thoracic Surgeons

Original Articles: General Thoracic

Pleural-Based Mesothelioma in Immune Competent Rats: A Model to Study Adenoviral Gene Transfer

John C. Kucharczuk, MD, Ashraf A. Elshami, MD, Hong Bing Zhang, W. Roy Smythe, MD, Harry C. Hwang, MD, James S. Tomlinson, MD, Kunjlata M. Amin, PhD, Leslie A. Litzky, MD, Steven M. Albelda, MD, Larry R. Kaiser, MD

Thoracic Surgery Section, Department of Surgery, Pulmonary/Critical Care Section, Department of Medicine, Department of Pathology, and Thoracic Oncology Research Laboratory, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania

Background. Despite multimodality approaches, pleural-based malignant mesothelioma remains a disease with a very poor prognosis. Novel therapeutic strategies such as gene therapy clearly are needed to improve the survival of patients with this neoplasm. To aid in the evaluation of new treatment strategies, animal models that closely mimic human disease are required. This article describes the establishment of a pleural-based model of malignant mesothelioma in immune-competent Fischer rats.

Methods.Via a modified left anterior lateral thorocotomy, a syngeneic malignant mesothelioma cell line, called II-45, was placed into the pleural cavity of Fischer rats.

Results.Placement of II-45 cells into the pleural cavity of Fischer rats results in a model of pleural mesothelioma that closely resembles the disease seen in patients and is highly reproducible, with animals dying within 1 month. We also demonstrate the feasibility of adenoviral-mediated gene transfer to normal mesothelial cells lining the pleural cavity, as well as to malignant cells deep within the substance of pleural-based malignant mesothelioma.

Conclusions.The model described here offers the opportunity to study a variety of new treatment modalities, especially somatic gene transfer, against pleural-based malignant mesothelioma in an immune competent setting.


Related Articles

Discussion
Ann. Thorac. Surg. 1995 60: 597-598. [Extract] [Full Text]

Invited Commentary
Scott M. Freeman
Ann. Thorac. Surg. 1995 60: 598. [Extract] [Full Text]



This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
I. Opitz, D. Lardinois, S. Arni, S. Hillinger, P. Vogt, B. Odermatt, V. Rousson, and W. Weder
Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment
Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 772 - 778.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
Intrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma.
J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 697 - 703.e3.


Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. I. Ebright, J. S. Zager, S. Malhotra, K. A. Delman, T. L. Weigel, V. W. Rusch, and Y. Fong
Replication-competent herpes virus NV1020 as direct treatment of pleural cancer in a rat model
J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 123 - 129.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
A. SCHERPEREEL, R. WIEWRODT, M. CHRISTOFIDOU-SOLOMIDOU, R. GERVAIS, J.-C. MURCIANO, S. M. ALBELDA, and V. R. MUZYKANTOV
Cell-selective intracellular delivery of a foreign enzyme to endothelium in vivo using vascular immunotargeting
FASEB J, February 1, 2001; 15(2): 416 - 426.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
E. S. Lambright, S. D. Force, M. E. Lanuti, D. S. Wasfi, K. M. Amin, S. M. Albelda, and L. R. Kaiser
Efficacy of repeated adenoviral suicide gene therapy in a localized murine tumor model
Ann. Thorac. Surg., December 1, 2000; 70(6): 1865 - 1871.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
P. Schwarzenberger, D. Lei, S. M. Freeman, P. Ye, A. Weinacker, C. Theodossiou, W. Summer, and J. K. Kolls
Antitumor Activity with the HSV-tk-gene-modified Cell Line PA-1-STK in Malignant Mesothelioma
Am. J. Respir. Cell Mol. Biol., August 1, 1998; 19(2): 333 - 337.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.